LNTH — Lantheus Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Lantheus Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	339	425	935	1,296	1,534
Cost of Revenue
Gross Profit	148	188	582	832	988
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	344	485	899	932	1,077
Operating Profit	-4.2	-59.9	35.6	365	457
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-11.5	-75	26.7	411	431
Provision for Income Taxes
Net Income After Taxes	-13.5	-71.3	28.1	327	312
Net Income Before Extraordinary Items
Net Income	-13.5	-71.3	28.1	327	312
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-13.5	-71.3	28.1	327	312
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.042	-1.21	0.403	5.73	4.28